Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patientsChisako Iriyama, Akihiro Tomita, Takaya Ichikawa et al.|PNAS Nexus|2025Cited by 10
Leukemogenic kinase <scp>FIP</scp>1L1‐<scp>PDGFRA</scp> and a small ubiquitin‐like modifier E3 ligase, <scp>PIAS</scp>1, form a positive cross‐talk through their enzymatic activitiesMakoto Ibata, Takeshi Kondo, Stephanie Darmanin et al.|Cancer Science|2016Cited by 4